ClinicalTrials.gg
Sign In
CompletedNCT06521983WBVUpdated Jul 30, 2024

The Effect of Whole Body Vibration on Muscle Elasticity

An interventional study of Whole body vibration in Lordosis; Postural, Lordosis and Hyperlordosis, sponsored by Gaziantep Islam Science and Technology University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-30.

Sponsored by Gaziantep Islam Science and Technology University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Nov 2023, registered Jul 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study examined the effect of whole-body vibration on pain and muscle elasticity in individuals with hyperlordosis and normal lordosis.

Flexible ruler for individuals' spinal curvatures (lumbar lordosis); back-lower back pain levels VAS; muscle elasticity Myoton Pro device; Physical functions will be evaluated with the Modified Oswestry low back pain scale.

Read the detailed description

This study examined the effect of whole-body vibration on pain and muscle elasticity in individuals with hyperlordosis and normal lordosis.

Flexible ruler for individuals' spinal curvatures (lumbar lordosis); back-lower back pain levels VAS; muscle elasticity Myoton Pro device; Physical functions will be evaluated with the Modified Oswestry low back pain scale.

The viscoelasticity properties ( tone, stiffness, elasticity) of the Musculus Trapezius and Musculus Pectoralis were assessed with MyotonPro® (Myoton AS, Estonia) during prone position on both sides.

Individuals will be divided into two groups: hyperlordosis and normal lordosis. Whole body vibration will be applied twice a week for six weeks, with a frequency of 30 Hz and an intensity of 2 mm.

A total of 28 females and males (14 individuals for each group) with hyperlordosis (>40°) and normal lordosis participated in the study.

02

Conditions studied

  • Lordosis; Postural
  • Lordosis
  • Hyperlordosis

Browse trials for

Keywords

  • Whole-body vibration
  • Lordosis
  • Hyperlordosis
03

In context

Lordosis

30 studies on the registry are indexed under Lordosis; 5 are open to participants now.

This study's enrollment of 28 is below the median of 50 across 15 interventional studies indexed under Lordosis.

Browse Lordosis studies →

Lead sponsor

Gaziantep Islam Science and Technology University is the lead sponsor of 43 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being over 18 years of age,
  • Having pain >5 according to VAS measurement,
  • Having normal lumbar lordosis angle between 30°-40°,
  • Having hyperlordosis angle >40°

Exclusion criteria

Exclusion Criteria:

  • Having Scheurmann kyphosis, ,
  • Having scoliosis (Cobb angle >10°),
  • Having other congenital spine abnormalities
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    LORDOSİS

    30-40

    Other: Whole body vibration

  • Experimental
    HYPERLORDOSİS

    40\<

    Other: Whole body vibration

Interventions

  • OtherWhole body vibration

    Whole body vibration will be applied while standing with a frequency of 30 Hz and an intensity of 2 mm by vibration machine

06

What researchers measure

Primary outcomes

  1. Muscle viscoelastic properties

    muscle stiffness

    Time frame: 6 weeks

Secondary outcomes

  1. Pain level

    Visual Analog Scale: between 0 -10 points; 0 (zero) no pain; 5 (five) Moderate pain; 10 (ten) Worst possible Pain

    Time frame: 6 weeks

07

Study locations

1 site
  • Gaziantep Islam Science and Technology University
    Gaziantep, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2023 to primary completion in Apr 2024, 5 months.

Of 11 interventional studies with no phase under Lordosis, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's 5 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2024
First posted
Jul 26, 2024
StartActual
Nov 5, 2023
Primary completionActual
Apr 20, 2024
CompletionActual
Jun 28, 2024
Last update
Jul 30, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06521983
Lead sponsor
Gaziantep Islam Science and Technology University
Responsible party
Gönül Elpeze (Assistant Proffessor, Gaziantep Islam Science and Technology University) — Principal investigator
First posted
Jul 26, 2024
Start date
Nov 5, 2023
Primary completion
Apr 20, 2024
Completion
Jun 28, 2024
Last update
Jul 30, 2024

Study contacts

Gonul Elpeze
principal investigator · Gaziantep Islam Science and Technology University Physical Therapy and Rehabilitation Department

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Lordosis →

Other studies from this sponsor

Gaziantep Islam Science and Technology University

Start the discussion